Table 2. Association between CD151 and/α3β1 expression and clinicopathological features.
|
(A) | |||
|---|---|---|---|
|
P-value |
|||
|
ILC |
|||
| Feature | α3β1 (high: n=69) | CD151 (high: n=83) | CD151/α3β1 (high: n=55) |
| α3 | 0.012 | ||
| CD151 | 0.012 | ||
| Size | 0.574 | 0.047 | 0.381 |
| Nodes | 0.464 | 0.277 | 0.101 |
| Stage | 0.656 | 0.019 | 0.387 |
| Grade | 0.093 | 0.343 | 0.019 |
| ErbB2 | 0.092 | 0.881 | 0.249 |
| ER/PR | 0.694 | 0.471 | 0.425 |
|
(B) | |||
|---|---|---|---|
|
P-value |
|||
|
IDC |
|||
| Feature | α3β1 (high: n=32) | CD151 (high: n=87) | CD151 /α3β1 (high: n=26) |
| α3β1 | <0.001 | ||
| CD151 | <0.001 | ||
| Size | 0.599 | 0.497 | 0.499 |
| Nodes | 0.271 | 0.076 | 0.413 |
| Stage | 0.545 | 0.030 | 0.174 |
| Grade | 0.163 | 0.041 | 0.162 |
| ErbB2 | >0.999 | 0.015 | 0.995 |
| ER/PR | 0.663 | 0.819 | 0.797 |
Abbreviations: ER/PR=oestrogen receptor/progesterone receptor; IDC=invasive ductal carcinoma; ILC=invasive lobular carcinoma. The bold values are statistically significant.